A survey on functional disabilities and perceived need for allied health and complementary therapies for Thai individuals with Parkinson’s disease

Article Sidebar

pdf
Published: Apr 26, 2022
Keywords:
Parkinson’s disease, functional disability, allied health, complementary therapy, alternative treatment

Main Article Content

Suweena Khacharoen
Motor Control and Neural Plasticity Laboratory, Faculty of Physical Therapy, Mahidol University, Nakhon Pathom Province, Thailand
Jarugool Tretriluxana
Motor Control and Neural Plasticity Laboratory, Faculty of Physical Therapy, Mahidol University, Nakhon Pathom Province, Thailand
Sira Boonprasop
Motor Control and Neural Plasticity Laboratory, Faculty of Physical Therapy, Mahidol University, Nakhon Pathom Province, Thailand
Prachaya Srivanitchapoom
Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Theeraya Upachit
Motor Control and Neural Plasticity Laboratory, Faculty of Physical Therapy, Mahidol University, Nakhon Pathom Province, Thailand

Abstract

Background: Evidence regarding functional disability and the need for alternative health care services to improve abilities among Thai individuals with Parkinson’s disease (PD) is limited.


Objectives: The study aims to survey PD patients on their functional difficulties and determined the correlation between personal- and disease-related factors on the difficulties they experience. Additionally, we asked about the need for, utilization of, and satisfaction with allied health care (AHC) and alternative complementary therapy (ACT) to minimize these difficulties in PD.


Materials and methods: Researchers conducted one-on-one interviews in a movement disorder clinic in a Thai university hospital. The survey consisted of interviews for personal and disease data at first, followed by the self-rating of functional disabilities and the need for and experience of AHC and ACT.


Results: Patients with severe disease had regressive disability in some activities. There were 4 factors related to the level of functional disability: stage of severity, duration of disease, cognitive performance, and depression score. Half of the participants needed treatment via AHC and ACT. Of the patients, 37%, 50% and 38.9% had experience with physical therapy, massage, and acupuncture, respectively. Almost all of them were satisfied with massage and physical therapy, while a small number of patients were satisfied with acupuncture.


Conclusion: These results indicate that functional disability worsens as the disease progresses. A small number of patients have experience with AHC and ACT; however, they need alternative treatment. Further research regarding related factors for utilizing AHC and ACT in Thai PD patients’ needs to be conducted.

Article Details

How to Cite
Khacharoen, S., Tretriluxana, J., Boonprasop, S., Srivanitchapoom, P., & Upachit, T. . (2022). A survey on functional disabilities and perceived need for allied health and complementary therapies for Thai individuals with Parkinson’s disease. Journal of Associated Medical Sciences, 55(2), 47–56. Retrieved from https://he01.tci-thaijo.org/index.php/bulletinAMS/article/view/252973
Issue
Vol. 55 No. 2 (2022): May-August
Section
Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Personal views expressed by the contributors in their articles are not necessarily those of the Journal of Associated Medical Sciences, Faculty of Associated Medical Sciences, Chiang Mai University.

References

Collaborators GUND, Feigin VL, Vos T, Alahdab F, Amit AML, Barnighausen TW, et al. Burden of neurological disorders across the US from 1990-2017: A global burden of disease study. JAMA Neurol. 2021; 78: 165-76 doi: 10.1001/jamaneurol.2020.4152.

Muangpaisan W, Siritipakorn P, Assantachai P. Development of a Thai Parkinson's Disease Screening Tool and the prevalence of parkinsonism and Parkinson's disease, based on a community survey in Bangkok. Neuroepidemiology. 2017; 49: 74-81 doi: 10.1159/000480510.

Raggi A, Leonardi M, Ajovalasit D, Carella F, Soliveri P, Albanese A, et al. Disability and profiles of functioning of patients with Parkinson's disease described with ICF classification. Int J Rehabil Res. 2011; 34: 141-50 doi: 10.1097/MRR.0b013e328344ae09.

Nijkrake MJ, Keus SH, Oostendorp RA, Overeem S, Mulleners W, Bloem BR, et al. Allied health care in Parkinson's disease: referral, consultation, and professional expertise. Mov Disord. 2009; 24: 282-6 doi: 10.1002/mds.22377.

Behari M, Srivastava AK, Pandey RM. Quality of life in patients with Parkinson's disease. Parkinsonism Relat Disord. 2005; 11: 221-6 doi: 10.1016/j.parkreldis.2004.12.005.

Bhidayasiri R, Boonmongkol T, Thongchuam Y, Phumphid S, Kantachadvanich N, Panyakaew P, et al. Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management. PLoS One. 2020; 15: e0243051 doi: 10.1371/journal.pone.0243051.

Kumaresan M, Khan S. Spectrum of non-motor symptoms in Parkinson's disease. Cureus. 2021; 13: e13275 doi: 10.7759/cureus.13275.

Roheger M, Kalbe E, Liepelt-Scarfone I. Progression of cognitive decline in Parkinson's disease. J Parkinsons Dis. 2018; 8: 183-93 doi: 10.3233/JPD-181306.

Tsiouris KM, Konitsiotis S, Koutsouris DD, Fotiadis DI. Prognostic factors of Rapid symptoms progression in patients with newly diagnosed Parkinson's disease. Artif Intell Med. 2020; 103: 101807 doi: 10.1016/ j.artmed.2020.101807.

Ambrosio L, Portillo MC, Rodriguez-Blazquez C, Rojo JM, Martinez-Martin P, Group E-PV. Influencing factors when living with Parkinson's disease: A cross-sectional study. J Clin Nurs. 2019; 28: 3168-76 doi: 10.1111/jocn.14868.

Sharpe G, Macerollo A, Fabbri M, Tripoliti E. Non-pharmacological treatment challenges in early Parkinson's disease for axial and cognitive symptoms: A mini review. Front Neurol. 2020; 11: 576569 doi: 10.3389/fneur.2020.576569.

Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, et al. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2018; 33: 1248-66 doi: 10.1002/mds.27372.

Qamar MA, Harington G, Trump S, Johnson J, Roberts F, Frost E. Multidisciplinary care in Parkinson's disease. Int Rev Neurobiol. 2017; 132: 511-23 doi: 10.1016/bs.irn.2017.02.001.

Bloem BR, Henderson EJ, Dorsey ER, Okun MS, Okubadejo N, Chan P, et al. Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care. Lancet Neurol. 2020; 19: 623-34 doi: 10.1016/S1474-4422(20)30064-8.

Nijkrake MJ, Keus SH, Kalf JG, Sturkenboom IH, Munneke M, Kappelle AC, et al. Allied health care interventions and complementary therapies in Parkinson's disease. Parkinsonism Relat Disord. 2007; 13 Suppl 3: S488-94 doi: 10.1016/S1353-8020(08)70054-3.

Aye YM, Liew S, Neo SX, Li W, Ng HL, Chua ST, et al. Patient-centric care for Parkinson's disease: From hospital to the community. Front Neurol. 2020; 11: 502 doi: 10.3389/fneur.2020.00502.

Keus SH, Bloem BR, Verbaan D, de Jonge PA, Hofman M, van Hilten BJ, et al. Physiotherapy in Parkinson's disease: Utilisation and patient satisfaction. J Neurol. 2004; 251: 680-7 doi: 10.1007/s00415-004-0402-7.

Kim SR, Lee TY, Kim MS, Lee MC, Chung SJ. Use of complementary and alternative medicine by Korean patients with Parkinson's disease. Clin Neurol Neurosurg. 2009; 111: 156-60 doi: 10.1016/j.clineuro.2008.09.011.

Deane KH, Ellis-Hill C, Jones D, Whurr R, Ben-Shlomo Y, Playford ED, et al. Systematic review of paramedical therapies for Parkinson's disease. Mov Disord. 2002; 17: 984-91 doi: 10.1002/mds.10197.

Ferry P, Johnson M, Wallis P. Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease. Postgrad Med J. 2002; 78: 612-4 doi: 10.1136/pmj.78.924.612.

Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson's disease. Neurology. 2001; 57: 790-4 doi: 10.1212/wnl.57.5.790.

Duits A, van der Heijden C, van Het Hoofd M, Roodbol G, Tiemessen M, Munneke M, et al. Psychosocial needs of patients and spouses justify a position of psychosocial health professionals in the multidisciplinary care for Parkinson's disease. Clin Park Relat Disord. 2020 ;3: 100064 doi: 10.1016/j.prdoa.2020.100064.

Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov Disord. 2004; 19: 1020-8 doi: 10.1002/mds.20213.

Francescutti C, Fusaro G, Leonardi M, Martinuzzi A, Sala M, Russo E, et al. Italian ICF training programs: describing and promoting human functioning and research. Disabil Rehabil. 2009; 31 Suppl 1: S46-9 DOI: 10.3109/09638280903317757.

King LA, Priest KC, Nutt J, Chen Y, Chen Z, Melnick M, et al. Comorbidity and functional mobility in persons with Parkinson disease. Arch Phys Med Rehabil. 2014; 95: 2152-7 doi: 10.1016/j.apmr.2014.07.396.

Cenci MA, Ohlin KE, Rylander D. Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia. Parkinsonism Relat Disord. 2009; 15 Suppl 3: S59-63 doi: 10.1016/S1353-8020(09)70782-5.

Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ, Group CS. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008; 70: 2241-7 doi: 10.1212/ 01.wnl.0000313835.33830.80.

Steiger MJ, Thompson PD, Marsden CD. Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1996; 61: 645-8 doi: 10.1136/ jnnp.61.6.645.

McColl CD, Reardon KA, Shiff M, Kempster PA. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. Mov Disord. 2002; 17: 1227-34 doi: 10.1002/mds.10244.

Gasparini F, Di Paolo T, Gomez-Mancilla B. Metabotropic glutamate receptors for Parkinson's disease therapy. Parkinsons Dis. 2013; 2013: 196028 doi: 10.1155/2013/196028.

Parkinson Study G. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. JAMA. 2000; 284: 1931-8 doi: 10.1001/jama.284.15.1931.

Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001; 16: 448-58 doi: 10.1002/mds.1090.

Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. Levodopa-induced dyskinesias. Mov Disord. 2007; 22: 1379-89 doi: 10.1002/mds.21475.

Post B, Merkus MP, de Haan RJ, Speelman JD, Group CS. Prognostic factors for the progression of Parkinson's disease: A systematic review. Mov Disord. 2007; 22: 1839-51; quiz 988 doi: 10.1002/mds.21537.

Visser M, Verbaan D, van Rooden S, Marinus J, van Hilten J, Stiggelbout A. A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health. 2009; 12: 392-6 doi: 10.1111/j.1524-4733.2008.00430.x.

Bloem BR, Eimers M, van Galen MS, Munneke M, Darweesh SKL. From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease. Eur J Neurol. 2021; 28: 775-82 doi: 10.1111/ene.14627.

Roberts AC, Rafferty MR, Wu SS, Miao G, Cubillos F, Simuni T, et al. Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease: A Parkinson's foundation (PF) QII study. Parkinsonism Relat Disord. 2021; 83: 115-22 doi: 10.1016/j.parkreldis.2020.11.024.

Radder DLM, Sturkenboom IH, van Nimwegen M, Keus SH, Bloem BR, de Vries NM. Physical therapy and occupational therapy in Parkinson's disease. Int J Neurosci. 2017; 127: 930-43 doi: 10.1080/ 00207454.2016.1275617.

Ginis P, Nackaerts E, Nieuwboer A, Heremans E. Cueing for people with Parkinson's disease with freezing of gait: A narrative review of the state-of-the-art and novel perspectives. Ann Phys Rehabil Med. 2018; 61: 407-13 doi: 10.1016/j.rehab.2017.08.002.

Gomez-Gonzalez J, Martin-Casas P, Cano-de-la-Cuerda R. Effects of auditory cues on gait initiation and turning in patients with Parkinson's disease. Neurologia (Engl Ed). 2019; 34: 396-407 doi: 10.1016/j.nrl.2016. 10.008.

Quinn L, Macpherson C, Long K, Shah H. Promoting physical activity via telehealth in people with Parkinson disease: The path forward after the COVID-19 pandemic? Phys Ther. 2020; 100: 1730-6 doi: 10.1093/ ptj/pzaa128.

Keeratitanont K, Jensen MP, Chatchawan U, Auvichayapat P. The efficacy of traditional Thai massage for the treatment of chronic pain: A systematic review. Complement Ther Clin Pract. 2015; 21: 26-32 doi: 10.1016/j.ctcp.2015.01.006.

Angelopoulou E, Anagnostouli M, Chrousos GP, Bougea A. Massage therapy as a complementary treatment for Parkinson's disease: A systematic literature review. Complement Ther Med. 2020; 49: 102340 doi: 10.1016/j.ctim.2020.102340.

Ellis T, de Goede CJ, Feldman RG, Wolters EC, Kwakkel G, Wagenaar RC. Efficacy of a physical therapy program in patients with Parkinson's disease: a randomized controlled trial. Arch Phys Med Rehabil. 2005 ;86: 626-32 doi: 10.1016/j.apmr.2004.08.008.

Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR. Physical therapy in Parkinson's disease: evolution and future challenges. Mov Disord. 2009; 24: 1-14 doi: 10.1002/mds.22141.

Lee SH, Lim S. Clinical effectiveness of acupuncture on Parkinson disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017; 96: e5836 doi: 10.1097/MD.0000000000005836.

Herd CP, Tomlinson CL, Deane KH, Brady MC, Smith CH, Sackley CM, et al. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease. Cochrane Database Syst Rev. 2012: CD002814 doi: 10.1002/14651858.CD002814.pub2.